Cargando…

Myopia control: short-term effect of 0.01% atropine vs. defocus incorporated multiple segment lenses—a retrospective study in European children

PURPOSE: To compare 0.01% atropine with DIMS spectacle lenses in the prevention of myopia progression in European children. METHODS: This was a retrospective study including data from pediatric European patients with myopia. From November 2021 to March 2022, only 0.01% atropine was prescribed becaus...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guimarães, Sandra, Barros da Silva, Patrícia, Oliveiros, Bárbara, Silva, Eduardo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Netherlands 2023
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10504187/ https://www.ncbi.nlm.nih.gov/pubmed/37420123 http://dx.doi.org/10.1007/s10792-023-02788-x

Ejemplares similares

Effect of atropine 0.01% on progression of myopia
por: Sen, Snigdha, et al.
Publicado: (2022)

Synergistic effects of defocus-incorporated multiple segments and atropine in slowing the progression of myopia
por: Huang, Zhu, et al.
Publicado: (2022)

A comparison of myopia control in European children and adolescents with defocus incorporated multiple segments (DIMS) spectacles, atropine, and combined DIMS/atropine
por: Nucci, Paolo, et al.
Publicado: (2023)

Effects of atropine 0.01% on refractive errors in children with myopia
por: Zhu, Xingxue, et al.
Publicado: (2023)

Author Correction: Synergistic effects of defocus-incorporated multiple segments and atropine in slowing the progression of myopia
por: Huang, Zhu, et al.
Publicado: (2023)

Clinical efficacy of 0.01% atropine in retarding the progression of myopia in children
por: Zhao, Qi, et al.
Publicado: (2020)

Analysis of Factors That May Affect the Effect of Atropine 0.01% on Myopia Control
por: Zhang, Xiaoyu, et al.
Publicado: (2020)

A multicenter Spanish study of atropine 0.01% in childhood myopia progression
por: Pérez-Flores, Inés, et al.
Publicado: (2021)

Overview on Defocus Incorporated Multiple Segments Lenses: A Novel Perspective in Myopia Progression Management
por: Carlà, Matteo Mario, et al.
Publicado: (2022)

Efficacy and Safety of Consecutive Use of 1% and 0.01% Atropine for Myopia Control in Chinese Children: The Atropine for Children and Adolescent Myopia Progression Study
por: Ye, Luyao, et al.
Publicado: (2022)

Myopia Control with Combination Low-Dose Atropine and Peripheral Defocus Soft Contact Lenses: A Case Series
por: Erdinest, Nir, et al.
Publicado: (2021)

Compounded 0.01% Atropine—What's in the Bottle?
por: Richdale, Kathryn, et al.
Publicado: (2023)

Effectiveness of 0.01% atropine in anisomyopic children
por: Hussain, Azfira, et al.
Publicado: (2023)

A Pilot Study on the Efficacy and Safety of 0.01% Atropine in German Schoolchildren with Progressive Myopia
por: Joachimsen, Lutz, et al.
Publicado: (2019)

Comparing the effects of highly aspherical lenslets versus defocus incorporated multiple segment spectacle lenses on myopia control
por: Guo, Hui, et al.
Publicado: (2023)

Decreased effectiveness of 0.01% atropine treatment for myopia control during prolonged COVID-19 lockdowns
por: Erdinest, Nir, et al.
Publicado: (2022)

The efficacy and safety of 0.01% atropine alone or combined with orthokeratology for children with myopia: A meta-analysis
por: Wang, Zengying, et al.
Publicado: (2023)

Effect of 0.01% Atropine on Accommodation in Myopic Teenagers
por: Li, Huixia, et al.
Publicado: (2022)

Efficacy of 0.01% low dose atropine and its correlation with various factors in myopia control in the Indian population
por: Chaurasia, Shweta, et al.
Publicado: (2022)

Use baseline axial length measurements in myopic patients to predict the control of myopia with and without atropine 0.01%
por: Rose, Loreto V. T., et al.
Publicado: (2021)

Defocus Incorporated Multiple Segments (DIMS) spectacle lenses slow myopia progression: a 2-year randomised clinical trial
por: Lam, Carly Siu Yin, et al.
Publicado: (2020)

Safety and efficacy of 0.02% and 0.01% atropine on controlling myopia progression: a 2-year clinical trial
por: Cui, Can, et al.
Publicado: (2021)

The Effects of 0.01% Atropine on Adult Myopes’ Contrast Sensitivity
por: Cheng, Ziyun, et al.
Publicado: (2021)

Efficacy of 0.01% atropine for myopia control in a randomized, placebo-controlled trial depends on baseline electroretinal response
por: Chan, Henry H. L., et al.
Publicado: (2022)

The effect of 0.01% atropine on ocular axial elongation for myopia children: A protocol for systematic review and meta-analysis
por: Gao, Yue, et al.
Publicado: (2022)

Effect of atropine 0.01% on myopia control in children aged 6–13 years during the 2022 lockdown in Shanghai
por: Yu, Manrong, et al.
Publicado: (2023)

Add-On Effect of 0.01% Atropine in Orthokeratology Wearers for Myopia Control in Children: A 2-Year Retrospective Study
por: Du, Linlin, et al.
Publicado: (2023)

Age-related results over 2 years of the multicenter Spanish study of atropine 0.01% in childhood myopia progression
por: Pérez-Flores, Inés, et al.
Publicado: (2023)

Myopia Control Effect Is Influenced by Baseline Relative Peripheral Refraction in Children Wearing Defocus Incorporated Multiple Segments (DIMS) Spectacle Lenses
por: Zhang, Hanyu, et al.
Publicado: (2022)

Characteristics of responders to atropine 0.01% as treatment in Asian myopic children
por: Lee, Lung-Chi, et al.
Publicado: (2022)

Comparison of two different orthokeratology lenses and defocus incorporated soft contact (DISC) lens in controlling myopia progression
por: Li, Na, et al.
Publicado: (2023)

Atropine 0.01% Eye Drops for Myopia Control in American Children: A Multiethnic Sample Across Three US Sites
por: Larkin, G. Luke, et al.
Publicado: (2019)

A Randomized Controlled Trial of the Effect of 0.01% Atropine Eye Drops Combined with Auricular Acupoint Stimulation on Myopia Progression
por: Kong, Xie-He, et al.
Publicado: (2021)

Observation of the effect of posterior scleral reinforcement combined with orthokeratology and 0.01% atropine in the treatment of congenital myopia: a case report
por: Yan, Chunxiao, et al.
Publicado: (2023)

Side effects of topical atropine 0.05% compared to 0.01% for myopia control in German school children: a pilot study
por: Joachimsen, Lutz, et al.
Publicado: (2021)

Effects of 0.01% Atropine Instillation Assessed Using Swept-Source Anterior Segment Optical Coherence Tomography
por: Mitsukawa, Tadahiro, et al.
Publicado: (2021)

Changes in pattern electroretinogram after application of 0.01% atropine eye drops
por: Kothari, Mihir, et al.
Publicado: (2019)

Efficacy of combined orthokeratology and 0.01% atropine solution for slowing axial elongation in children with myopia: a 2-year randomised trial
por: Kinoshita, Nozomi, et al.
Publicado: (2020)

Efficacy of combined orthokeratology and 0.01% atropine for myopia control: the study protocol for a randomized, controlled, double-blind, and multicenter trial
por: Yuan, Ying, et al.
Publicado: (2021)

The effect of 0.01% atropine and orthokeratology on ocular axial elongation for myopia children: A meta-analysis (a PRISMA-compliant article)
por: Yu, Yan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_gd3vbeqnv1g2i0h75fs94uje61